Spero Therapeutics, Inc. Consulting Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDED & RESTATED CONSULTING AGREEMENT
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
2025
Consulting Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
2025
Consulting Agreement, effective as of August 5, 2024, by and between the Registrant and John C. Pottage, Jr., M.D
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2024
Consulting Agreement, effective as of August 29, 2024, by and between the Registrant and Kamal Hamed
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2024
Consulting Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2024
Consulting Agreement, dated June 12, 2023, by and between the Registrant and Danforth Advisors, LLC
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2023
Consulting Agreement, dated June 13, 2023, by and between the Registrant and Ankit Mahadevia, M.D
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2023
Amendment 1 to Consulting Agreement, dated August 4, 2022, by and between the Registrant and Cristina Larkin
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
2022
Consulting Agreement, dated May 3, 2022, by and between the Registrant and David Melnick, M.D
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2022
Consulting Agreement, dated May 3, 2022, by and between the Registrant and Cristina Larkin
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2022
Consulting Agreement, dated November 4, 2019, by and between the Registrant and Danforth Advisors, LLC
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
MA
2020
Consulting Agreement, dated April 18, 2019, by and between the Registrant and David P. Southwell
Consulting Agreements
Spero Therapeutics, Inc.
Biotechnology
2020